- Our Company
- About Us
- Healthcare Professionals
- Patients and Carers
- News and Events
- Contact Us
FMC Website Year End Returns 2014 Welcome to Renal Pharma – the pharmaceutical business division of Fresenius Medical Care.
Aiming at comprehensive care that integrates the best possible dialysis therapy and patient support is the key to increasing life expectancy and improving quality of life for patients with end-stage renal disease.
With Renal Pharmaceuticals, Fresenius Medical Care aims to provide a range of drugs for treating patients with chronic and acute renal failure, complementing our leadership in dialysis technology and renal services. The Renal Pharmaceutical portfolio expands the role of Fresenius Medical Care as a fully integrated renal care provider. The initial portfolio of dialysis-related drugs comprises phosphate binders and a novel drug for anaemia management.
For more information please contact us.
As part of a significant move towards greater transparency and building greater trust between the medical community, industry and patients across the UK, pharmaceutical companies are publishing the annual aggregate of payments made to healthcare professionals and to organisations. To view these details for 2014, please click here.
To view the details for 2013, please click here.